Filed: 11/13/2023ACC: 0001085146-23-004322
📋 What this filing means
CHI ADVISORS LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $252.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$252.31M
Total AUM (reported)
42.06M
Total Shares
Allocation by class
COM$215.46M85.4%
SPON ADS NEW$14.03M5.6%
COMMON STOCK$6.20M2.5%
COM NEW$5.12M2.0%
DAILY S&P BIOTEC$4.63M1.8%
CLASS A ORD$3.42M1.4%
COM SER A$3.07M1.2%
Portfolio Concentration
Top 3$119.21M47.2%
4–10$86.21M34.2%
11–25$46.67M18.5%
Rest$207.0K0.1%
Top 3 weight
47.2%
Top 10 weight
81.4%
Voting Authority Distribution
Total shares with voting rights: 42.06M
Sole
Full voting authority
42.06M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other26
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
PLIANT THERAPEUTICS INC
DFNDShares3.15M
TypeSH
Market value$52.32M
20.74%
Sole
3.15M
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.02M
TypeSH
Market value$35.99M
14.27%
Sole
3.02M
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
DFNDShares3.41M
TypeSH
Market value$30.90M
12.25%
Sole
3.41M
Shared
0.00
None
0.00
ACELYRIN INC
DFNDShares2.26M
TypeSH
Market value$23.01M
9.12%
Sole
2.26M
Shared
0.00
None
0.00
ORCHARD THERAPEUTICS PLC
DFNDShares12.32M
TypeSH
Market value$14.03M
5.56%
Sole
12.32M
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares3.41M
TypeSH
Market value$13.49M
5.35%
Sole
3.41M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
DFNDShares407.63K
TypeSH
Market value$13.00M
5.15%
Sole
407.63K
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
DFNDShares2.18M
TypeSH
Market value$9.44M
3.74%
Sole
2.18M
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares215K
TypeSH
Market value$7.66M
3.04%
Sole
215K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares2.83M
TypeSH
Market value$5.57M
2.21%
Sole
2.83M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
DFNDShares568.38K
TypeSH
Market value$5.41M
2.14%
Sole
568.38K
Shared
0.00
None
0.00
INOZYME PHARMA INC
DFNDShares1.27M
TypeSH
Market value$5.33M
2.11%
Sole
1.27M
Shared
0.00
None
0.00
SYROS PHARMACEUTICALS INC
DFNDShares1.30M
TypeSH
Market value$5.12M
2.03%
Sole
1.30M
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
DFNDShares92.89K
TypeSH
Market value$4.66M
1.85%
Sole
92.89K
Shared
0.00
None
0.00
DIREXION SHS ETF TR
DFNDShares225K
TypeSH
Market value$4.63M
1.84%
Sole
225K
Shared
0.00
None
0.00
2SEVENTY BIO INC
DFNDShares1M
TypeSH
Market value$3.93M
1.56%
Sole
1M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares60K
TypeSH
Market value$3.42M
1.36%
Sole
60K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
DFNDShares864.82K
TypeSH
Market value$3.32M
1.32%
Sole
864.82K
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares348.84K
TypeSH
Market value$3.07M
1.22%
Sole
348.84K
Shared
0.00
None
0.00
OMEGA THERAPEUTICS INC
DFNDShares1.06M
TypeSH
Market value$2.27M
0.90%
Sole
1.06M
Shared
0.00
None
0.00
BLACK DIAMOND THERAPEUTICS I
DFNDShares720K
TypeSH
Market value$2.07M
0.82%
Sole
720K
Shared
0.00
None
0.00
RALLYBIO CORP
DFNDShares390.73K
TypeSH
Market value$1.32M
0.52%
Sole
390.73K
Shared
0.00
None
0.00
DISC MEDICINE INC
DFNDShares25K
TypeSH
Market value$1.17M
0.47%
Sole
25K
Shared
0.00
None
0.00
GRAPHITE BIO INC
DFNDShares230.94K
TypeSH
Market value$572.7K
0.23%
Sole
230.94K
Shared
0.00
None
0.00
FREELINE THERAPEUTICS HLDGS
DFNDShares86.65K
TypeSH
Market value$372.6K
0.15%
Sole
86.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PLIANT THERAPEUTICS INCDFND | COM | 3.15M | SH | $52.32M 20.74% | 3.15M | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.02M | SH | $35.99M 14.27% | 3.02M | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCDFND | COM | 3.41M | SH | $30.90M 12.25% | 3.41M | 0.00 | 0.00 |
ACELYRIN INCDFND | COM | 2.26M | SH | $23.01M 9.12% | 2.26M | 0.00 | 0.00 |
ORCHARD THERAPEUTICS PLCDFND | SPON ADS NEW | 12.32M | SH | $14.03M 5.56% | 12.32M | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 3.41M | SH | $13.49M 5.35% | 3.41M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCDFND | COM | 407.63K | SH | $13.00M 5.15% | 407.63K | 0.00 | 0.00 |
IKENA ONCOLOGY INCDFND | COM | 2.18M | SH | $9.44M 3.74% | 2.18M | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 215K | SH | $7.66M 3.04% | 215K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 2.83M | SH | $5.57M 2.21% | 2.83M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCDFND | COM | 568.38K | SH | $5.41M 2.14% | 568.38K | 0.00 | 0.00 |
INOZYME PHARMA INCDFND | COM | 1.27M | SH | $5.33M 2.11% | 1.27M | 0.00 | 0.00 |
SYROS PHARMACEUTICALS INCDFND | COM NEW | 1.30M | SH | $5.12M 2.03% | 1.30M | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPDFND | COM | 92.89K | SH | $4.66M 1.85% | 92.89K | 0.00 | 0.00 |
DIREXION SHS ETF TRDFND | DAILY S&P BIOTEC | 225K | SH | $4.63M 1.84% | 225K | 0.00 | 0.00 |
2SEVENTY BIO INCDFND | COMMON STOCK | 1M | SH | $3.93M 1.56% | 1M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 60K | SH | $3.42M 1.36% | 60K | 0.00 | 0.00 |
OVID THERAPEUTICS INCDFND | COM | 864.82K | SH | $3.32M 1.32% | 864.82K | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 348.84K | SH | $3.07M 1.22% | 348.84K | 0.00 | 0.00 |
OMEGA THERAPEUTICS INCDFND | COMMON STOCK | 1.06M | SH | $2.27M 0.90% | 1.06M | 0.00 | 0.00 |
BLACK DIAMOND THERAPEUTICS IDFND | COM | 720K | SH | $2.07M 0.82% | 720K | 0.00 | 0.00 |
RALLYBIO CORPDFND | COM | 390.73K | SH | $1.32M 0.52% | 390.73K | 0.00 | 0.00 |
DISC MEDICINE INCDFND | COM | 25K | SH | $1.17M 0.47% | 25K | 0.00 | 0.00 |
GRAPHITE BIO INCDFND | COM | 230.94K | SH | $572.7K 0.23% | 230.94K | 0.00 | 0.00 |
FREELINE THERAPEUTICS HLDGSDFND | SPONSORED ADS | 86.65K | SH | $372.6K 0.15% | 86.65K | 0.00 | 0.00 |
Page 1 of 2